Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Mucosal and Systemic Immune Responses to Influenza H7N9 Antigen HA1-2 Co-Delivered Intranasally with Flagellin or Polyethyleneimine in Mice and Chickens.

Song L, Xiong D, Song H, Wu L, Zhang M, Kang X, Pan Z, Jiao X.

Front Immunol. 2017 Apr 5;8:326. doi: 10.3389/fimmu.2017.00326. eCollection 2017.

2.

Analysis of the Changes in Expression Levels of Sialic Acid on Influenza-Virus-Infected Cells Using Lectin-Tagged Polymeric Nanoparticles.

Cho J, Miyake Y, Honda A, Kushiro K, Takai M.

Front Microbiol. 2016 Jul 21;7:1147. doi: 10.3389/fmicb.2016.01147. eCollection 2016.

3.

Limited Efficacy of Antibacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection.

Metzger DW, Furuya Y, Salmon SL, Roberts S, Sun K.

J Infect Dis. 2015 Aug 1;212(3):445-52. doi: 10.1093/infdis/jiv066. Epub 2015 Feb 3.

4.

Enhanced Mucosal Antibody Production and Protection against Respiratory Infections Following an Orally Administered Bacterial Extract.

Pasquali C, Salami O, Taneja M, Gollwitzer ES, Trompette A, Pattaroni C, Yadava K, Bauer J, Marsland BJ.

Front Med (Lausanne). 2014 Oct 30;1:41. doi: 10.3389/fmed.2014.00041. eCollection 2014.

5.

Live attenuated influenza virus increases pneumococcal translocation and persistence within the middle ear.

Mina MJ, Klugman KP, Rosch JW, McCullers JA.

J Infect Dis. 2015 Jul 15;212(2):195-201. doi: 10.1093/infdis/jiu804. Epub 2014 Dec 11.

6.

Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung.

Rynda-Apple A, Patterson DP, Douglas T.

Nanomedicine (Lond). 2014;9(12):1857-68. doi: 10.2217/nnm.14.107. Review.

7.

CD4+ T cell help guides formation of CD103+ lung-resident memory CD8+ T cells during influenza viral infection.

Laidlaw BJ, Zhang N, Marshall HD, Staron MM, Guan T, Hu Y, Cauley LS, Craft J, Kaech SM.

Immunity. 2014 Oct 16;41(4):633-45. doi: 10.1016/j.immuni.2014.09.007. Epub 2014 Oct 9.

8.

T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.

Li J, Arévalo MT, Chen Y, Chen S, Zeng M.

Int J Infect Dis. 2014 Oct;27:37-43. doi: 10.1016/j.ijid.2014.05.016. Epub 2014 Aug 27.

9.

Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge.

Sanchez MV, Ebensen T, Schulze K, Cargnelutti D, Blazejewska P, Scodeller EA, Guzmán CA.

PLoS One. 2014 Aug 20;9(8):e104824. doi: 10.1371/journal.pone.0104824. eCollection 2014.

10.

Advances in influenza vaccination.

Reperant LA, Rimmelzwaan GF, Osterhaus AD.

F1000Prime Rep. 2014 Jun 2;6:47. doi: 10.12703/P6-47. eCollection 2014. Review.

11.

Asthma increases susceptibility to heterologous but not homologous secondary influenza.

Furuya Y, Roberts S, Hurteau GJ, Sanfilippo AM, Racine R, Metzger DW.

J Virol. 2014 Aug;88(16):9166-81. doi: 10.1128/JVI.00265-14. Epub 2014 Jun 4.

12.
13.

Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice.

Mina MJ, McCullers JA, Klugman KP.

MBio. 2014 Feb 18;5(1). pii: e01040-13. doi: 10.1128/mBio.01040-13.

14.

Immune dysfunction and bacterial coinfections following influenza.

Metzger DW, Sun K.

J Immunol. 2013 Sep 1;191(5):2047-52. doi: 10.4049/jimmunol.1301152. Review.

15.

Olfactory bulb and hypothalamic acute-phase responses to influenza virus: effects of immunization.

Zielinski MR, Souza G, Taishi P, Bohnet SG, Krueger JM.

Neuroimmunomodulation. 2013;20(6):323-33. doi: 10.1159/000351716. Epub 2013 Aug 16.

16.

Multipronged CD4(+) T-cell effector and memory responses cooperate to provide potent immunity against respiratory virus.

Strutt TM, McKinstry KK, Marshall NB, Vong AM, Dutton RW, Swain SL.

Immunol Rev. 2013 Sep;255(1):149-64. doi: 10.1111/imr.12088. Review.

17.

Diet-induced obese mice exhibit altered heterologous immunity during a secondary 2009 pandemic H1N1 infection.

Milner JJ, Sheridan PA, Karlsson EA, Schultz-Cherry S, Shi Q, Beck MA.

J Immunol. 2013 Sep 1;191(5):2474-85. doi: 10.4049/jimmunol.1202429. Epub 2013 Jul 31.

18.

Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.

Loving CL, Lager KM, Vincent AL, Brockmeier SL, Gauger PC, Anderson TK, Kitikoon P, Perez DR, Kehrli ME Jr.

J Virol. 2013 Sep;87(17):9895-903. doi: 10.1128/JVI.01038-13. Epub 2013 Jul 3.

19.

T cell-mediated host immune defenses in the lung.

Chen K, Kolls JK.

Annu Rev Immunol. 2013;31:605-33. doi: 10.1146/annurev-immunol-032712-100019. Review.

20.

Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.

Brewoo JN, Powell TD, Jones JC, Gundlach NA, Young GR, Chu H, Das SC, Partidos CD, Stinchcomb DT, Osorio JE.

Vaccine. 2013 Apr 3;31(14):1848-55. doi: 10.1016/j.vaccine.2013.01.038. Epub 2013 Feb 1.

Supplemental Content

Support Center